ConductScience.org, home

Paper6961950

Regulation of human natural killing by levamisole.

Shau H and 1 other. Cancer Immunol Immunother, 1982. Cited by 5 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Regulation of human natural killing by levamisole. Papers, record 6961950. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6961950

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Regulation of human natural killing by levamisole.
PubMed
Journal
Cancer Immunol Immunother
PubMed
Year
1982
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
0.19
iCite
Revised in PubMed
2024-04-26
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shau HH
2Dawson JRJ R

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cytotoxicity, ImmunologicMajor topic
Leukemia, Myeloid, AcuteMajor topic
LevamisoleMajor topic
LymphocytesMajor topic
Cell Line
Cell Survival
Humans
Kinetics
Leukocytes
Lymphocyte Activation

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA 13070NCI NIH HHSUnited StatesR01CA013070PubMed and NIHNIH RePORTER
CA 14049NCI NIH HHSUnited StatesR01CA014049PubMed and NIHNIH RePORTER

Download CSV of grants

References20

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16166701Characteristics of human large granular lymphocytes and relationship to natural killer and K cells.J Exp Med1981https://conductscience.org/library/papers/6166701PubMed
2173469Effects of levamisole and imidazole on lymphocyte proliferation and cyclic nucleotide levels.Cell Immunol1975https://conductscience.org/library/papers/173469PubMed
34585358Letter: Levamisole and the immune response.N Engl J Med1973https://conductscience.org/library/papers/4585358PubMed
455529Levamisole in advanced human breast cancer.Lancet1976https://conductscience.org/library/papers/55529PubMed
5436929High nonspecific reactivity of normal lymphocytes against mycoplasma-infected target cells in cytotoxicity assays.Eur J Immunol1979https://conductscience.org/library/papers/436929PubMed
636225Inhibition of in vitro lymphocyte function by cystic and ascitic fluids from ovarian cancer patients.Cancer Res1979https://conductscience.org/library/papers/36225PubMed
76163551Interferon induction and augmentation of natural-killer activity by Staphylococcus protein A.Cell Immunol1981https://conductscience.org/library/papers/6163551PubMed
86165008Influence of anti-mouse interferon serum on the growth and metastasis of tumor cells persistently infected with virus and of human prostatic tumors in athymic nude mice.Proc Natl Acad Sci U S A1981https://conductscience.org/library/papers/6165008PubMed
9540153[Effect of levamisole on the cytotoxic activity of normal lymphocytes in tissue culture].Biull Eksp Biol Med1979https://conductscience.org/library/papers/540153PubMed
107195412Mycoplasma contamination in human tumor cell lines: effect on interferon induction and susceptibility to natural killing.J Immunol1981https://conductscience.org/library/papers/7195412PubMed
111222761Allogeneic tumor enhancement by levamisole, a new immunostimulatory compound: studies on cell-mediated immunity and humoral antibody response.Eur J Cancer (1965)1975https://conductscience.org/library/papers/1222761PubMed
127240748In vivo effects of anti-asialo GM1. I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice.J Immunol1981https://conductscience.org/library/papers/7240748PubMed
131098727Immunopotentiation with levamisole in resectable bronchogenic carcinoma: a double-blind controlled trial; Study Group for Bronchogenic Carcinoma.Br Med J1975https://conductscience.org/library/papers/1098727PubMed
14150448Cell-mediated cytotoxicity against virus-infected target cells in humans. II. Interferon induction and activation of natural killer cells.J Immunol1978https://conductscience.org/library/papers/150448PubMed
151206735Effects of levamisole on in vivo and in vitro murine host response to syngeneic transplantable tumor.J Natl Cancer Inst1975https://conductscience.org/library/papers/1206735PubMed
164718515Drug-induced restoration of cutaneous delayed hypersensitivity in anergic patients with cancer.N Engl J Med1973https://conductscience.org/library/papers/4718515PubMed
176970103Delineation of an effector population responsible for natural killing and antibody-dependent cellular cytotoxicity in man.Clin Immunol Immunopathol1981https://conductscience.org/library/papers/6970103PubMed
18292811Differences in resistance of metastatic tumor cells and cells from local tumor growth to cytotoxicity of natural killer cells.J Natl Cancer Inst1979https://conductscience.org/library/papers/292811PubMed
19367948Do natural killer cells engage in regulated reactions against self to ensure homeostasis?Immunol Rev1979https://conductscience.org/library/papers/367948PubMed
206157727Spontaneous cytoxicity against virus-infected cells: cellular immunoadsorption on infected cell monolayers.J Immunol1980https://conductscience.org/library/papers/6157727PubMed

Download CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
6573908Human natural killing against ovarian carcinoma.Br J Cancer1983https://conductscience.org/library/papers/6573908PubMed
6500627The role of the lysosome in natural killing: inhibition by lysosomotropic vital dyes.Immunology1984https://conductscience.org/library/papers/6500627PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6961950

GET https://conductscience.org/api/papers/v1/6961950/authors